$184.17
-0.31-0.17%
At Close: -
$184.17
00.00%
After Hours: Sep 20, 4:00 PM EDT
15 minutes delayed
Krystal Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Krystal Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $0.94 | $0.62 | 51.6 % |
Mar 2024 | 2024-05-06 | $0.46 | $0.15 | 206.7 % |
Dec 2023 | 2024-02-26 | $0.30 | $-0.37 | 181.1 % |
Sep 2023 | 2023-11-06 | $-0.67 | $-0.15 | -346.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $70.28M | $64.43M | 9.09 % |
Mar 2024 | 2024-05-06 | $45.25M | $47.42M | -4.58 % |
Dec 2023 | 2024-02-26 | $42.14M | $28.61M | 47.3 % |
Sep 2023 | 2023-11-06 | $8.56M | $6.37M | 34.3 % |
Krystal Biotech (KRYS) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $0.94, which beat the estimate of $0.62.
The Actual Revenue was $70.3M, which beat the estimate of $64.4M.
Browse earnings estimates, EPS, and revenue on all stocks.